SCHEMBL2637571

SCHEMBL2637571

Cc1ccc(S(=O)(=O)Nc2c(=O)[nH]n3c(=O)cc(-c4ccccc4)[nH]c23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
GAA P10253 4/20 0.50
KDM4E B2RXH2 4/20 0.50
HPGD P15428 3/20 0.50
CYP2C19 P33261 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 2/20 0.46
CA12 O43570 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
LMNA P02545 2/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
CA1 P00915 1/20 0.43
CYP2C9 P11712 2/20 0.41
FFAR4 Q5NUL3 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637523 0.89 FFAR4 (0.44) ALDH1A1GAAKDM4EHPGDCYP2C19
SCHEMBL2637663 0.89 PGR (0.42) ALDH1A1GAAKDM4EHPGDCYP2C19
SCHEMBL3412133 0.75 KEAP1 (0.46) ALDH1A1GAACYP2C19MAPTCA12
SCHEMBL2637343 0.72 ALDH1A1 (0.46) ALDH1A1MAPTMEN1KMT2APOLB
SCHEMBL2637795 0.72 MEN1 (0.44) ALDH1A1GAAKDM4EHPGDMAPT
SCHEMBL2637170 0.71 MAPT (0.43) ALDH1A1GAAKDM4EHPGDMAPT
SCHEMBL2637507 0.71 ERCC1 (0.47) ALDH1A1GAAKDM4EHPGDMAPT
SCHEMBL2637590 0.69 KDM4E (0.41) ALDH1A1GAAKDM4EHPGDCYP2C19
SCHEMBL3411702 0.69 CYP1A2 (0.53) ALDH1A1GAAKDM4EHPGDCYP2C19
SCHEMBL2637580 0.68 GRM5 (0.44) ALDH1A1KDM4ELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed